Clover Health Investments Corp. [NASDAQ: CLOV] loss -2.38% on the last trading session, reaching $7.38 price per share at the time. The company report on April 5, 2021 that The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CLOV, REGI and LDOS.
The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Clover Health Investments, Corp. (NASDAQ:CLOV).
Clover Health Investments Corp. represents 103.50 million in outstanding shares, while the company has a total market value of $3.06 billion with the latest information. CLOV stock price has been found in the range of $7.3208 to $7.69.
If compared to the average trading volume of 16.87M shares, CLOV reached a trading volume of 4201849 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Clover Health Investments Corp. [CLOV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $12.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Credit Suisse have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 09, 2021. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on February 02, 2021, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $15, while JP Morgan analysts kept a Neutral rating on CLOV stock.
The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.73, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 4.43. The Price to Book ratio for the last quarter was 0.96, with the Price to Cash per share for the same quarter was set at 0.00.
Trading performance analysis for CLOV stock
Clover Health Investments Corp. [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.63. With this latest performance, CLOV shares dropped by -10.98% in over the last four-week period, additionally sinking by -40.77% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 36.27, with the RSI for the last a single of trading hit 35.71, and the three-weeks RSI is set at 37.31 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 10.41, while it was recorded at 7.41 for the last single week of trading, and 11.13 for the last 200 days.
Clover Health Investments Corp. [CLOV]: A deeper dive into fundamental analysis
Reflecting on the efficiency of the workforce at the company, Clover Health Investments Corp. [CLOV] managed to generate an average of -$4,408 per employee.Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.30.
An analysis of insider ownership at Clover Health Investments Corp. [CLOV]
There are presently around $134 million, or 13.10% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: SUSQUEHANNA INTERNATIONAL GROUP, LLP with ownership of 2,147,623, which is approximately New of the company’s market cap and around 0.30% of the total institutional ownership; GROUP ONE TRADING, L.P., holding 1,915,441 shares of the stock with an approximate value of $14.14 million in CLOV stocks shares; and ALYESKA INVESTMENT GROUP, L.P., currently with $13.18 million in CLOV stock with ownership of nearly 156.643% of the company’s market capitalization.
Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 79 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 14,187,911 shares. Additionally, 79 investors decreased positions by around 46,838,430 shares, while 1 investors held positions by with 42,915,098 shares. The mentioned changes placed institutional holdings at 18,111,243 shares, according to the latest SEC report filing. CLOV stock had 67 new institutional investments in for a total of 12,014,953 shares, while 66 institutional investors sold positions of 33,969,301 shares during the same period.